Resultados da pesquisa - Wanner, Christoph

The ABCs in the Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: An Introductory Remark on Expert Perspectives Por Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Magnesium in disease Por Geiger, Helmut, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

The Obesity Paradox and the Role of Inflammation Por Drechsler, Christiane, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Uromodulin in the Bloodstream: Old Wine in a New Wineskin Por Kraus, Daniel, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Will the FAbry STabilization indEX make its way to everyday clinical practice? Por Cairns, Tereza, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Present and future of CONNECT: a new and compelling project of modern medicine Por Capasso, Giovambattista, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Fifty years of ERA-EDTA Registry—a registry in transition Por Jager, Kitty J, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes—A Proposed MARE Definition Por Prischl, Friedrich C., Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Life/2020—the future of kidney disease Por Stenvinkel, Peter, Fouque, Denis, Wanner, Christoph

Obter o texto integral Obter o texto integral

A Janus‐headed electrolyte and ‘RALES' disease’ Por Kraus, Daniel, Wanner, Christoph, Kraus, Bettina J.

Obter o texto integral Obter o texto integral Obter o texto integral

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease Por Heerspink, Hiddo J L, Fouque, Denis, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting list Por Herzog, Anna Laura, Kalogirou, Charis, Wanner, Christoph, Lopau, Kai

Obter o texto integral Obter o texto integral Obter o texto integral

Understanding competing risks: a simulation point of view Por Allignol, Arthur, Schumacher, Martin, Wanner, Christoph, Drechsler, Christiane, Beyersmann, Jan

Obter o texto integral Obter o texto integral Obter o texto integral

Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles Por Oder, Daniel, Vergho, Dorothee, Ertl, Georg, Wanner, Christoph, Nordbeck, Peter

Obter o texto integral Obter o texto integral Obter o texto integral

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy Por Müntze, Jonas, Salinger, Tim, Gensler, Daniel, Wanner, Christoph, Nordbeck, Peter

Obter o texto integral Obter o texto integral Obter o texto integral

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Por Winkler, Karl, Wanner, Christoph, Drechsler, Christiane, Lilienthal, Jürgen, März, Winfried, Krane, Vera

Obter o texto integral Obter o texto integral Obter o texto integral

Antibodies to Platelet Factor 4–Heparin Complex and Outcome in Hemodialysis Patients with Diabetes Por Krane, Vera, Berger, Mario, Lilienthal, Jürgen, Winkler, Karl, Schambeck, Christian, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Por Winkler, Karl, Wanner, Christoph, Drechsler, Christiane, Lilienthal, Jürgen, März, Winfried, Krane, Vera

Obter o texto integral Obter o texto integral

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study Por Locatelli, Francesco, Spasovski, Goce, Dimkovic, Nada, Wanner, Christoph, Dellanna, Frank, Pontoriero, Giuseppe

Obter o texto integral Obter o texto integral Obter o texto integral

Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time Por Krieter, Detlef H., Kerwagen, Simon, Rüth, Marieke, Lemke, Horst-Dieter, Wanner, Christoph

Obter o texto integral Obter o texto integral Obter o texto integral